Biomedical Engineering Reference
In-Depth Information
87. Staels, B. and F. Kuipers,
Bile acid sequestrants and the treatment of
type 2 diabetes mellitus.
Drugs, 2007.
67
(10): p. 1383-1392.
88. Huval, C.C., et al.,
Novel cholesterol lowering polymeric drugs obtained
by molecular imprinting.
Macromolecules, 2001.
34
(6): p. 1548-1550.
89. Wang, Y.J., et al.,
Specific binding of cholic acid by cross-linked polymers
prepared by the hybrid imprinting method.
Polymer, 2007.
48
(19): p.
5565-5571.
90. Tamaru, S. and I. Hamachi,
Recent progress of phosphate derivatives
recognition utilizing artificial small molecular receptors in aqueous
media.
Recognit Anions, 2008.
129
: p. 95-125.
91. Gale, P.A., S.E. Garcia-Garrido, and J. Garric,
Anion receptors based on
organic frameworks: highlights from 2005 and 2006.
Chem Soc Rev,
2008.
37
(1): p. 151-190.
92. Holmes-Farley, S.R., et al.,
Design and characterization of sevelamer
hydrochloride: A novel phosphate-binding pharmaceutical.
J Macromol
Sci Pure Appl Chem, 1999.
A36
(7-8): p. 1085-1091.
93. Amin, N.,
The impact of improved phosphorus control: use of sevelamer
hydrochloride in patients with chronic renal failure.
Nephrol Dial
Transplant, 2002.
17
(2): p. 340-345.
94. Goldsmith, D.R., et al.,
Sevelamer hydrochloride: a review of its use
for hyperphosphataemia in patients with end-stage renal disease on
haemodialysis.
Drugs, 2008.
68
(1): p. 85-104.
95. Liu, Z.D. and R.C. Hider,
Design of clinically useful iron(III)-selective
chelators.
Med Res Rev, 2002.
22
(1): p. 26-64.
96. Raymond, K.N.,
Biomimetic metal encapsulation.
Coordination Chem
Rev, 1990.
105
: p. 135-153.
97. Polomoscanik, S.C., et al.,
Hydroxamic acid-containing hydrogels for
nonabsorbed iron chelation therapy: Synthesis, characterization, and
biological evaluation.
Biomacromolecules, 2005.
6
(6): p. 2946-2953.
98. Zhou, T., et al.,
Iron binding dendrimers: A novel approach for the
treatment of haemochromatosis.
J Med Chem, 2006.
49
(14): p. 4171-
4182.
99. Zhou, T., et al.,
Synthesis and iron(III)-chelating properties of novel
3-hydroxypyridin-4-one hexadentate ligand-containing copolymers.
Biomacromolecules, 2008.
9
(5): p. 1372-1380.
100. Louie, T.J., et al.,
Tolevamer, a novel nonantibiotic polymer, compared with
vancomycin in the treatment of mild to moderately severe Clostridium
difficile-associated diarrhea.
Clin Infect Dis, 2006.
43
(4): p. 411-420.
101. Vercruysse, K.P. and G.D. Prestwich,
Hyaluronate derivatives in drug
delivery.
Crit Rev Ther Drug Carrier Syst, 1998.
15
(5): p. 513-555.
Search WWH ::
Custom Search